Overview
Adviti Naik practices practicing medicine in Doha, Qatar.
Naik is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Triple-Negative Breast Cancer, Testicular Cancer, Breast Cancer, and Trophoblastic Tumor Placental Site.
They are actively involved in clinical research, co-authoring 21 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Adviti Naik
Is Adviti Naik a top-rated expert for Triple-Negative Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Adviti Naik is classified as an Advanced expert for Triple-Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Adviti Naik participate in research or clinical trials?
Yes. Adviti Naik has published 21 articles and abstracts on conditions like Triple-Negative Breast Cancer. You can view a list of Adviti Naik's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Testicular CancerNaik isAdvanced. Learn about Testicular Cancer.
- Triple-Negative Breast Cancer
- Experienced
- Breast CancerNaik isExperienced. Learn about Breast Cancer.
- Trophoblastic Tumor Placental Site